ASML Holding NV (0QB8)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 1,489.60 |
|---|---|
| 52-week range | 818.26 – 1,738.52 |
| Return, 1 month / 3 months | +4.2% / −6.4% |
| Return, 1 year / 3 years | +71.2% / +168.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 41.3% |
| Worst drawdown (1 year) | -20.1% |
| Average daily value traded | 186.36M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ASML Holding NV is a Dutch technology company based in Veldhoven that designs and builds lithography systems used to manufacture semiconductors. Its machines pattern silicon wafers for chipmakers, and its product range includes extreme ultraviolet and deep ultraviolet lithography equipment. Customers are semiconductor manufacturers around the world, including foundries and memory producers, who use the systems in their fabrication plants. The company also provides related services and software that support chipmaking processes.
On this site ASML Holding NV appears as a stock on the London Exchange (UK), code 0QB8, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ASML Holding NV (0QB8) trades on the London Exchange in UK. It last closed at EUR 1,489.60 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 594 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 71.2% and over the last three months it fell 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.9% | ||
| From 52-week high | -13.0% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.5% | ||
| 6-month return | 20.2% | ||
| 12-month return, skipping the last month | 64.3% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.1% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 186.36M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.5% |
|---|---|
| 1 month | +4.2% |
| 3 months | −6.4% |
| 6 months | +20.2% |
| 1 year | +71.2% |
| 3 years | +168.0% |
| 5 years | +132.4% |
Signals
| 50-day / 200-day average | 1,516.67 / 1,368.14 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 53.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jul 2026 | EUR 1.8800 |
| 24 Apr 2026 | EUR 2.7000 |
| 9 Feb 2026 | EUR 1.6000 |
| 28 Oct 2025 | EUR 1.6000 |
| 28 Jul 2025 | EUR 1.6000 |
| 25 Apr 2025 | EUR 1.8400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.